MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
MariMed's revenue for the twelve months ending Sep 30, 2026 was $167.28M, up 6.5% year over year. For fiscal 2025 it was $159.83M, up 1.3% from the year before. Over ten years it grew 62.2% a year on average. The highest annual figure on record is $159.83M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $159.83M | +1.3% |
| FY2024 | Dec 31, 2024 | $157.71M | +6.1% |
| FY2023 | Dec 31, 2023 | $148.60M | +10.9% |
| FY2022 | Dec 31, 2022 | $134.01M | +10.3% |
| FY2021 | Dec 31, 2021 | $121.46M | +138.7% |
| FY2020 | Dec 31, 2020 | $50.90M | +11.6% |
| FY2019 | Dec 31, 2019 | $45.60M | +284.8% |
| FY2018 | Dec 31, 2018 | $11.85M | +95.3% |
| FY2017 | Dec 31, 2017 | $6.07M | +70.2% |
| FY2016 | Dec 31, 2016 | $3.56M | +180.6% |
| FY2015 | Dec 31, 2015 | $1.27M | +1337.1% |
| FY2014 | Dec 31, 2014 | $88.38K | +9677.0% |
| FY2013 | Dec 31, 2013 | $904 | +15.2% |
| FY2012 | Dec 31, 2012 | $785 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $44.23M | +8.5% |
| Q2 FY2026 | Jun 30, 2026 | $41.93M | +6.1% |
| Q1 FY2026 | Mar 31, 2026 | $39.48M | +4.2% |
| Q4 FY2025 | Dec 31, 2025 | $41.65M | +6.9% |
| Q3 FY2025 | Sep 30, 2025 | $40.76M | +0.4% |
| Q2 FY2025 | Jun 30, 2025 | $39.51M | -2.3% |
| Q1 FY2025 | Mar 31, 2025 | $37.91M | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | $38.95M | +0.1% |
| Q3 FY2024 | Sep 30, 2024 | $40.60M | +4.6% |
| Q2 FY2024 | Jun 30, 2024 | $40.44M | +10.7% |
| Q1 FY2024 | Mar 31, 2024 | $37.93M | +10.3% |
| Q4 FY2023 | Dec 31, 2023 | $38.90M | +8.6% |
| Q3 FY2023 | Sep 30, 2023 | $38.80M | +14.4% |
| Q2 FY2023 | Jun 30, 2023 | $36.52M | +10.7% |
| Q1 FY2023 | Mar 31, 2023 | $34.38M | +9.9% |
| Q4 FY2022 | Dec 31, 2022 | $35.83M | +15.4% |
| Q3 FY2022 | Sep 30, 2022 | $33.91M | +37.6% |
| Q2 FY2022 | Jun 30, 2022 | $32.99M | +62.0% |
| Q1 FY2022 | Mar 31, 2022 | $31.28M | +132.4% |
| Q4 FY2021 | Dec 31, 2021 | $31.04M | +223.0% |
| Q1 FY2021 | Mar 31, 2021 | $24.64M | +230.1% |
| Q4 FY2020 | Dec 31, 2020 | $20.36M | +292.1% |
| Q3 FY2020 | Sep 30, 2020 | $13.46M | +19.9% |
| Q2 FY2020 | Jun 30, 2020 | $9.61M | -62.6% |
| Q1 FY2020 | Mar 31, 2020 | $7.47M | +112.4% |
| Q4 FY2019 | Dec 31, 2019 | $5.19M | +50.9% |
| Q3 FY2019 | Sep 30, 2019 | $11.22M | +230.9% |
| Q2 FY2019 | Jun 30, 2019 | $25.67M | +774.0% |
| Q1 FY2019 | Mar 31, 2019 | $3.52M | +68.8% |
| Q4 FY2018 | Dec 31, 2018 | $3.44M | +117.7% |
| Q3 FY2018 | Sep 30, 2018 | $3.39M | +97.7% |
| Q2 FY2018 | Jun 30, 2018 | $2.94M | +81.2% |
| Q1 FY2018 | Mar 31, 2018 | $2.08M | +81.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.58M | +10.6% |
| Q3 FY2017 | Sep 30, 2017 | $1.72M | +96.4% |
| Q2 FY2017 | Jun 30, 2017 | $1.62M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.15M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.43M | – |
| Q3 FY2016 | Sep 30, 2016 | $873.55K | – |
See a number that looks wrong?